Tregoning Kathleen 4
4 · Spero Therapeutics, Inc. · Filed Jan 7, 2022
Insider Transaction Report
Form 4
Tregoning Kathleen
Director
Transactions
- Award
Stock Option (Right to Buy)
2022-01-05$9.03/sh+4,428$39,985→ 4,428 totalExercise: $13.19Exp: 2032-01-05→ Common Stock (4,428 underlying)
Footnotes (2)
- [F1]This stock option shall vest in four quarterly installments on the last day of each calendar quarter during the calendar year subject to the Reporting Person's continued service as a non-employee director.
- [F2]This stock option was issued to the Reporting Person, who elected to take stock options in lieu of $40,000 in cash compensation for services as a director, pursuant to the Issuer's non-employee director compensation policy.